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Abstract
Background: Cerebral malaria (CM) is a major cause of malaria mortality. Sequestration of infected red blood cells
and leukocytes in brain vessels coupled with the production of pro-inflammatory factors contribute to CM. CXCL-
10 a chemokine that is chemotactic to T cells has been linked to fatal CM. Mice deficient for CXCL-10 gene are
resistant to murine CM, while antibody ablation of CXCL-10 enhanced the production of regulatory T cells (CD4
+Cd25+Foxp3+) and IL-10 which regulate the immune system. Interleukin-2 (IL-2), a pro-inflammatory cytokine
implicated in malaria pathogenesis has also been shown to be a key regulator of Foxp3. However the role of
Foxp3 in resistant murine CM is not well understood.
Methods: The hypothesis that resistance of CXCL-10-/- mice to murine CM may be due to enhanced expression of
Foxp3 in concert with IL-10 and IL-2 was tested. CXCL-10-/- and WT C57BL/6 mice were infected with Plasmodium
berghei ANKA and evaluated for CM symptoms. Brain, peripheral blood mononuclear cells (PBMCs) and plasma
were harvested from infected and uninfected mice at days 2, 4 and 8. Regulatory T cells (CD4+CD25+) and non-T
regs (CD4+CD25-) were isolated from PBMCs and cultured with P. berghei antigens in vitro with dendritic cells as
antigen presenting cells. Regulatory T cell transcription and specific factor Foxp3, was evaluated in mouse brain
and PBMCs by realtime-PCR and Western blots while IL-10, and IL-2 were evaluated in plasma and cultured
supernatants by ELISA.
Results: Wild type mice exhibited severe murine CM symptoms compared with CXCL-10-/- mice. Foxp3 mRNA and
protein in brain and PBMC’s of CXCL-10-/- mice was significantly up-regulated (p < 0.05) by day 4 post-infection (p.
i) compared with WT. Plasma levels of IL-10 and IL-2 in infected CXCL-10-/- were higher than in WT mice (p <
0.05) at days 2 and 4 p.i. Ex-vivo CD4+CD25+ T cells from CXCL-10-/- re-stimulated with P. berghei antigens
produced more IL-10 than WT CD4+CD25+ T cells.
Conclusion: The results indicate that in the absence of CXCL-10, the resulting up-regulation of Foxp3, IL-10 and IL-
2 may be involved in attenuating fatal murine CM.
Background
Cerebral malaria (CM) is a major cause of malaria mor-
tality in endemic countries. The current paradigm of
CM pathogenesis suggests that parasite proliferation
activates endothelial cells to produce adhesion molecules
that enable sequestration of infected and uninfected red
blood cells (RBCs) in brain capillaries which obstruct
brain microvessels which results in severe inflammatory
processes that lead to CM syndrome. Recently it has
been reported that regulatory inflammatory responses
are associated with CM but the mechanism by which
they regulate CM pathogenesis is unclear. For example
mice lacking T-cells do not develop CM, and CM is
attenuated when CD4+ and CD8+ T-cells are blocked
[1]. Thus, blocking activation of T cells appears to
decrease the risk of CM severity.
The suppressive mechanism by which T- cells control
CM pathogenesis is not fully appreciated. Regulatory T-
cells (T-regs;CD4+CD25+Foxp3+) are a class of T-cells
which limit excessive activation of T-cells, and
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been implicated in many infectious diseases but their
role in CM immunopathogenesis is unclear. Recent
reports indicate that chemokines involved in the recruit-
ment of T-cells, during CM pathogenesis also recruit
CD4+CD25+Foxp3+ [2-8]. For instance, increased level
of the interferon-inducible protein-10 (CXCL-10) in CM
patients is tightly associated with the fatal CM pheno-
type in children [5]. CXCL-10 and its receptor CXCR3
are required for the development of murine CM [6].
Also, CXCL-10 is specific for effector T-cell recruitment
during infection and, therefore, its deletion reduces
T-cell trafficking, which enhances production of CD4
+CD25+Foxp3+ and suppressive cytokines interleukin-
10 (IL-10) and tumor growth factor- b1( T G F - b1) [9].
Interestingly, loss of CD4+CD25+Foxp3+ during simian
immunodeficiency viral infection for example has been
linked to changes in the expression of CXCL-10 [10].
Interleukin-2 (IL-2), which is produced by Th1 cells, is
one of the potent inflammatory cytokines mediating
multiple immune responses on activated B cells, mono-
cytes, and natural killer (NK) cells. Treatments of Plas-
modium yoelii 17XL infected mice with this cytokine
resulted in accumulation of T cells in the brain making
resistant mice susceptible to CM [11]. Interleukin-2 is a
key regulator of Foxp3, a specific marker for CD4
+CD25+Foxp3+.
During Plasmodium infection, the balance between
host pro-inflammatory and anti-inflammatory immune
responses play important roles in pathogenesis of CM.
Aw e ak pro-inflammatory response may lead to persis-
tence and replication of parasites while an excessive
pro-inflammatory response may result in immunopatho-
logical consequences such as CM. Therefore, identifying
regulatory mechanisms that control CM pathogenesis is
important in developing interactions for CM. Regulatory
T-cells (CD4+CD25+Foxp3+) are specialized T-cells
which maintain immune system homeostasis. They con-
stitute approximately 10% of host T-cells population
[12,13]. Regulatory T-cells suppress activation and
recruitment of T cells via production of suppressive
cytokines such as IL-10 and TGF-b1 [14,15], to limit the
ability of dendritic cells to activate T-cells, which cause
malaria related inflammation [16].
The hypothesis of this study is that a deficiency of
CXCL-10 in murine CM will enhance the production of
Foxp3 (CD4+CD25+Foxp3+), IL-10 and IL-2, which will
minimize or prevent fatal CM. To this end, experiments
were conducted with CXCL-10-/- and wild type C57BL/
6 mice and they were infected with Plasmodium berghei
A N K A ,ar o d e n tm a l a r i ap a r a s i t ec o m m o n l yu s e da s
murine CM to ascertain the role of Foxp3, IL-10 and
IL-2 in fatal CM pathogenesis.
Methods
Mice and Plasmodium berghei ANKA parasite
All studies were carried out with C57BL/6 wild type
(WT) and CXCL-10 knock-out mice (CXCL-10-/-) aged
6-8 weeks. Mice were purchased from Jackson’s labora-
tory (Bar Harbour, Maine USA), screened to ensure
they were pathogen-free and were maintained at the
Animal facility, at Morehouse School of Medicine on
12 h light/12 h dark cycle with access to water and food
ad libitum. Stocks of P. berghei ANKA parasitized blood
were obtained from Malaria Research and Reference
Reagent Resources (MR 4) (Mansass, VA USA).
Evaluation of parasitaemia and disease
Both WT and CXCL-10-/- mice were intraperitoneally
injected with 10
6 P. berghei parasitized blood to cause
murine CM. Control mice were sham injected with
uninfected blood. Each batch consisted of equal num-
bers of infected and control mice. Parasitaemia was
monitored by Giemsa-stained blood smears using light
microscopy. Parasitaemia and survival of CXCL-10-/-
and WT were evaluated. Mice were sacrificed at Days 2,
4 and 8, (post-infection p.i) to harvest brain, blood and
spleen for analysis of murineC Mi n d u c e dm a r k e r s .A l l
procedures were performed in accordance with national
regulations on animal experimentation and welfare, and
the Care of Laboratory Animal Resources (CLAR) guide-
line was followed to minimize animal pain.
Messenger RNA isolation and quantitative real-time RT-
PCR analysis of Foxp3
RNA isolation and cDNA synthesis
Since CM involves both pathophysiology of the brain,
the transcript levels of Foxp3 gene (specific marker for
T-regs) was evaluated in mouse brain, and PBMC dur-
ing P. berghei infection. Messenger RNA was isolated
from infected and uninfected brain tissue and PBMC
samples using Trizol reagent (Invitrogen, CA, USA) per
manufacturer’s instructions. Brain tissue samples were
homogenized and PBMCs pelleted, and lysed by Trizol
by repetitive pipetting. Chloroform was added to homo-
genates and incubated, followed by centrifugation at
12,000 g for 15 mins at 4°C. The aqueous phase
obtained after centrifugation was pipetted into fresh
tubes and RNA was precipitated by centrifugation at
12,000 g for 10 mins at 4°C in isopropanol. RNA sam-
ples were then washed, DNase treated and quantified.
One microgram (1 μg) of DNase treated RNA was con-
verted to cDNA using the Bio-Rad iScript cDNA synth-
esis kit (BioRad CA). Complementary DNA (cDNA) was
synthesized by incubating the reaction mix at 25°C for
5 mins, 42°C for 30 mins and 85°C for 5 mins. cDNA
samples were stored at -20°C until used.
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Quantitative realtime-PCR was performed using the
MyiQ real-time PCR detection system (Bio-Rad, CA
USA). Polymerase Chain Reaction (PCR) was carried in
a5 0μL reaction volume: 25 μL of iQ SYBR Green
Supermix, 0.5 μL each of specific primer mix (100 nM
as final concentration of each primer), 2 μLo fc D N A
and 19 μL of nuclease-free water.
Samples were run in duplicates in 96-well plate (Bio-
Rad, CA USA) with Foxp3 specific primers, (5’-GG
CCCTTCTCCAGGACAGA-3’; 5’GCTGATCATGGCT
GGGTTGT-3’) and -actin primers (5’-TGGGTCA
GAAGGACTCCTATG-3’, 5’-CAGGCAGCTCATAG
CTCTTCT-3’) respectively.
Protein isolation, SDS-PAGE and Western blot analysis of
Foxp3
To determine if the expression of Foxp3 mRNA was
translated into protein in the brain, protein was isolated
from whole mice brains using lysis buffer (phosphate-
buffered saline containing 0.05% Triton X-100, 0.15 M
NaCl, 2 mM EDTA, 1 mM phenylmethylsulphonyl
fluoride, and 20 μg aprotinin/ml). The total concentra-
tion of protein in the sample was determined by Lowry
method, so that 30 μg of protein could be subjected to
12% SDS-PAGE. The separated protein was then blotted
onto nitrocellulose membranes and probed with mono-
clonal antibody against mouse Foxp3 (Santa Cruz Bio-
technology, Inc, CA USA) at a concentration of 1:2000,
and anti-a-tubulin monoclonal antibodies (Sigma-
Aldrich, MO, USA) as internal control at a concentra-
tion of 1:4,000. Goat anti-mouse IgG Horse Radish
Peroxidase (HRP), BioRad, CA, USA) conjugate was
used as a secondary antibody at 1:6000. A chemilumi-
nescent substrate for the detection of HRP, (SuperSignal
West Pico Chemilumiscent Substrate, PIERCE Thermo
Fisher Scientific, IL, USA) was used to detect Foxp3
(48 kD) and a-tubulin (50 kD) proteins in mouse brain.
Preparation of plasma samples from blood
In order to evaluate the induction of IL-10 and TGF-
b1, and Th1 cytokine IL-2 during P. berghei infection,
heparinized blood samples from infected and uninfected
mice were collected. Blood was centrifuged for 15 mins
at 3,000 g and plasma samples were collected and stored
until used.
Isolation of peripheral blood mononuclear cells (PBMC)
from spleen
The spleen is an important lymphoid organ where T-cell
induction occurs during malaria infection, and is also
involved in the destruction of parasitized RBCs in
infected mice. Therefore, to obtain induced T-cells dur-
ing P. berghei infection, PBMC were obtained from
spleen, and T-cells purified for further analysis. Briefly,
spleens from infected and uninfected mice were col-
lected at Days 2, 4 and 8 post-infections. Using a 70 μm
cell strainer (BD Bioscience CA USA) and plunger of
syringe, splenic cells were teased through the cell strai-
ner into a petri dish, keeping the cell strainer suspended
in complete RPMI 1640 (10% FBS, 1% L-glutamine and
Penicillin-streptomycin). Cells were collected and centri-
fuged at 1200 rpm for 5 minutes at 4°C and pellets were
collected. Red blood cells in pellets were lysed with RBC
lysis buffer (Sigma, MO USA). Peripheral blood mono-
nuclear cells (PBMCs) pellets were resuspended in com-
plete RPMI 1640 medium until used.
Isolation of CD4+CD25+ regulatory T cells from splenic
PBMC
Regulatory T-cells (CD4+CD25+) were isolated from
splenic PBMC using the Miltenyi magnetic beads and
columns system according to manufacturer’si n s t r u c -
tions (Miltenyi Biotec Inc. CA USA). Regulatory T cells
were isolated in a two-step procedure. First, non-CD4
+
T-cells, CD8
+, g/δ, B cells, NK cells, dendritic cells,
monocytes, granulocytes, and erythroid cells, were indir-
ectly labeled magnetically by using a cocktail of biotin-
conjugated antibodies at the appropriate titers according
to manufacturer’s recommendation and were magneti-
cally labelled with anti-Biotin microbeads for depletion.
Subsequently, cells were processed with labelled CD25
microbeads to purify CD4+CD25+ T-cell population
from cell suspension. CD4+ CD25+ and CD4+CD25- T-
cells were purified with mouse anti-CD25-PE antibody
and anti-PE microbeads according to manufacturer’s
recommendation. Cell numbers and viability were deter-
mined. Purified CD4+CD25+ (>95% purity, data not
shown) were suspended in complete RPMI 1640 med-
ium until used.
Preparation of Plasmodium berghei ANKA antigens for
restimulation assay
Plasmodium berghei ANKA crude antigens were pre-
pared per the method of Kima and colleagues [17]. Plas-
modium berghei ANKA parasitized RBCs were washed
twice with Hanks Balanced Salt Solution (HBSS). Cells
were centrifuged at 1,100 × g for 10 mins to remove
leukocytes (buffy coat). Cells were diluted to a concen-
tration of 10
9 PRBC/mL and were subjected to three
freeze and thaw cycles. Cells were centrifuged at
100,000 × g for 1 h. Cells from uninfected red blood
cell controls were subjected to the same procedure.
Supernatants containing crude antigen were quantified
using the Quant-IT™ protein assay kit with the Qubit
fluorometer (Invitrogen, USA), and frozen at -20°C until
used. Crude protein lysate at 50 μg/mL was used to res-
timulate purified cells in vitro.
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cells with P. berghei ANAKA parasite antigens
High mRNA levels of Foxp3 in PBMC collected at day 4
using the qRT-PCR analysis showed the highest levels
of CD4+CD25+Foxp3+, hence CD4+CD25+ and
CD4+CD25-T-cells were purified from infected and con-
trol spleens at Day 4 from both WT and CXCL-10-/-
mice. They were restimulated in vitro with P. berghei
antigens to determine and compare cellular production
of CD4+CD25+Foxp3+ associated anti-inflammatory
cytokines IL-10 and TGF-b1. To this end, 5 × 10
5 cells/
well were cultured with P. berghei antigens (50 μg/mL)
and dendritic cells as antigen presenting cells (APC).
Cells cultured with supernatants prepared from uninfected
red blood cells were used as negative controls. Cells were
cultured for 5 days. Six hours( 6h r s )b e f o r eh a r v e s t i n g ,
phorbol-12-myristate-13-acetate (PMA) (50 ng/mL) and
ionomycin (1 μg/mL) were added to cultures to induce the
production of cytokines to measurable levels in vitro. Cul-
tured cells were harvested and centrifuged and the super-
natants frozen at -20°C until they were used.
Analysis of IL-10, IL-2 and TGF-b1 in plasma and cell
culture supernatants
The levels of IL-10, TGF-b1 and IL-2 in plasma samples
collected from heparinized blood and supernatants from
P. berghei antigen restimulated CD4+CD25+ and CD4
+CD25-T-cells were determined using a quantikine
ELISA kit (R&D systems (MN USA) per manufacturer’s
instructions. Interleukin-10, TGF-b1 and IL-2 detection
methods were similar except that for TGF-b1 detection,
plasma and supernatants were activated with 10 μLo f
1NHCL/40 μL of plasma or supernatant for 10 minutes,
and subsequently neutralized with 8 μL of 1.2 N NaOH/
0.5HEPES. Sample mixture was diluted 60-fold accord-
ing to manufacturers’ instructions prior to commencing
the assay.
Briefly, 50 μL samples, controls and standards were
prepared and added to the respective IL-10, TGF-b1
and IL-2 antibody coated microplate wells. After incuba-
tion and washing, 100 μL of IL-10, TGF-b1a n dI L - 2
conjugates were added to each well. Samples were
washed again and substrates were added to the complex
and incubated further. The reaction was stopped and
optical densities were read at 540 nm. Duplicate read-
ings of samples were averaged and the averages of zero
standard optical densities were subtracted. A standard
curve was plotted and the concentrations of IL-10 and
TGF-b1 in plasma and supernatants and IL-2 in plasma
were evaluated. Because samples for TGF-b1 detection
have been diluted 60-fold in the activation step prior to
the assay, the measured concentrations were multiplied
by the dilution factor (60) to obtain the actual concen-
tration of TGF-b1 in the sample.
Statistical analysis
Statistical differences between Foxp3, IL-10 and IL-2
production in P. berghei-infected and uninfected as well
as between infected CXCL-10-/- and WT mice were
determined by student two-tailed test, and p < 0.05 was
considered statistically significant. Graph pad prism sta-
tistical software version 5.0 was used for all analysis.
Results
Plasmodium berghei ANKA infection in CXCL-10-/- and WT
mice
During infection with P. berghei, WT mice exhibited
characteristic symptoms as expected of murine CM
including ruffled furs, weakness and ataxia compared
with the CXCL-10-/- mice. However, there was no sig-
nificant difference in parasitaemia between CXCL-10-/-
and WT mice (Figure 1).
Foxp3 mRNA expression is up-regulated in brain in P.
berghei-infected CXCL-10-/- than in WT mice
Forkhead transcription factor 3 (Foxp3) mRNA was sig-
nificantly elevated at Day 4 post-infection (p < 0.05)
when compared with control mice (Figure 2A). WT
mice showed no difference in Foxp3 mRNA expression
between P. berghei-infected and control mice in brain at
day 2 and 4 post-infection (Figure 2B). Foxp3 mRNA
expression was higher in P. berghei-infected in CXCL-
10-/- mice at Day 2 and 4, and later at day 4 (p < 0.05)
in WT mice (Figure 2C).
Foxp3 protein expression in mouse brain correlates with
mRNA expression during P. berghei ANKA infection in
CXCL-10-/- and WT
Western Blots analysis of Foxp3 protein expression indi-
cated that Foxp3 proteins (48 kD) in infected CXCL-
10-/- peaked at day 4 at higher level than in uninfected
controls at day 2 and 8 post-infection (Figures 2A and
2B). In WT mouse brain, Foxp3 protein expression was
significantly elevated at day 8 post-infection than at days
2 and 4, and in uninfected controls (Figure 1B). There
was a direct relationship between mRNA and protein
expression of Foxp3 in mouse brains of both CXCL-
10-/- and WT during P. berghei ANKA infection (Fig-
ures 1A and 1B). The expression of a-tubulin (50 kD)
(’housekeeping gene’, for internal control) was similar in
all sample analysed (Figures 2A and 2B).
Foxp3 mRNA expression is up-regulated in PBMC of P.
berghei-infected CXCL-10-/- than in WT mice
Foxp3 mRNA increased in PBMC of infected CXCL-
10-/- mice at day 2 and 4 greater than control, declining
by day 8 p.i. Interestingly, increased in Foxp3 mRNA in
PBMCs of infected WT at day 2, 4 and 8 were not statis-
tically significant when compared with it corresponding
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infected CXCL-10-/- at day 4 was significantly up-regu-
lated (~88%) compared with infected WT mice (Figure
3C). There was no differences in Foxp3 mRNA expres-
sion between infected PBMCs of CXCL-10-/- and WT at
day 2 and 8 (Figure 3C). In all mice, P. berghei infection
induced significant amount of Foxp3 mRNA expression
in brain and PBMCs in CXCL-10-/- at day 4 post-infec-
tion when compared with WT.
Plasmodium berghei ANKA induces early production of IL-
10 in CXCL-10-/-
Plasma production of IL-10 in plasma at days 4 and 8 in
both infected CXCL-10-/- and WT mice was elevated
when compared with controls (Figures 4A and 4B), indi-
cating that parasites may be responsible for altering IL-
10 levels in both WT and CXCL-10-/- mice. Interleukin-
10 levels were higher at Day 4 in infected CXCL-10-/-
than was observed for WT. In CXCL-10-/-, IL-10 levels
did not change significantly by Days 4 and 8. Infected
WT mice, on the other hand, had higher levels IL-10 at
day 8 than at day 4 (Figure 4B). These observations sug-
gest that IL-10 levels increased about 250% from day 4 to
day 8 (late stage) post-infection in WT compared to what
occurred from day4 to day8 in CXCL-10-/-.
IL-2 in CXCL-10-/- mice is elevated in P. berghei infected
mice
Induction of IL-2 in peripheral blood started early at day
2 and was significantly elevated (p < 0.05) at day 4 post-
infection compared with uninfected controls in CXCL-
10-/- mice (Figure 5A). Levels of IL-2 declined at day 8
post-infection.
Levels of IL-2 during P. berghei infection in WT mice
b e g a na td a y4a n dw a sh i g h e rw h e nc o m p a r e dw i t hI L -
2e x p r e s s i o na td a y s2 ,8a sw e l la su n i n f e c t e dc o n t r o l s
(Figure 5B). It was observed that there is a significant
induction of IL-2 in CXCL-10-/- than in WT, at day 2
(~40%,) and 4 (~80%, p < 0.05) post-infection. There
was no significant differences between IL-2 levels in
CXCL-10-/- and WT at day 8 (Figure 5C).
Plasmodium berghei ANKA antigen induces CD4+CD25+
and CD4+CD25- T cells to produce IL-10
Cells from WT and CXCL-10-/- mice stimulated with P.
berghei antigens produced higher amounts of IL-10 than
cells stimulated with supernatants from uninfected cells
in RPMI 1640 medium alone (Figures 6A and 6B). Fig-
ure 6C indicates that CXCL-10-/- CD4+CD25+ T-cells
IL-10 production was higher (~30%) and statistically sig-
nificant (p < 0.05) than that of WT. There were no dif-
ferences in IL-10 production between CD4+CD25- from
CXCL-10-/- and WT mice (Figure 6C). The ELISA
assay could not detect differences in TGF-b1 protein
production between CXCL-10-/- and WT.
Discussion
Although several mechanisms have been proposed to
explain cerebral malaria immunopathogenesis, the pre-
cise mechanisms is still unknown. Dysregulation of
homeostasis of pro- and anti- inflammatory factors has
been linked to the severity of CM. For instance, over
production of pro-inflammatory cytokines resulted in
dysfunction of the blood-brain barrier (BBB) leading to
CM complications [18-21].
Recently, a number of chemokines and their corre-
sponding receptors were implicated in CM pathogenesis
[2-4]. Studies conducted in our laboratory and elsewhere
using human CM samples from Ghana and India
revealed that excessive production of CXCL-10 in severe
malaria patients is an important predictor of mortality
risk in CM [4,21]. These studies demonstrated that there
were significant increase in pro-inflammatory markers
including interleukin-8 (IL-8), interleukin-1 receptor ago-
nist (IL-ra), interferon-inducible protein-10 (CXCL-10),
macrophage inflammatory protein-1beta (MIP-1b), solu-
ble tumor necrosis factor receptor-1 and 2 (sTNF-R1 and
sTNF-R2) in patients who died of CM [5].
Interferon gamma inducible protein-10 (CXCL-10)
levels in serum were independently associated with fatal
CM [4,21]. Thymus (T) cells produce CXCL-10, and,
therefore, a significant up-regulation of CXCL-10 in sera
of patients dying of CM indicates a high level of activa-
tion of T-cells associated with CM. CXCL-10 is a
Figure 1 Parasitaemia in Plasmodium berghei ANKA (10
6)
infected Wild type and CXCL-10-/- C57/BL6 mice at days 2, 4, 6
and 8 post-infection. Parasitaemia in infected wild type and CXCL-
10-/- was monitored daily by Giemsa-stained blood smears
collected from the tail vein using light microscopy and counting at
least 300 thin film of red blood cells. Mice were sacrificed at Days 2,
4 and 8, (post-infection p.i) to harvest brain, blood and spleen for
analysis of murine CM induced markers.
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binds the CXCR3 receptor which is expressed by acti-
vated T-cells [22]. Thymus (T) cells play a major role in
CM immunopathogenesis although the mechanism by
which their regulation modulates CM severity is not
understood [23,24]. Mice without T-cells do not develop
CM and CM is attenuated by blocking CD4+ and CD8+
T- cells [1]. Thus it is logical that blocking T-cells or
interfering with T-cell activation will decrease risk of
fatal CM.
In this study CD4+CD25+Foxp3+ transcription factor
and specific cell marker Foxp3 mRNA and protein in P.
berghei-infected mice was up-regulated in mouse brain.
Brain and PBMC Foxp3 expression induced by P. ber-
ghei were significantly up-regulated in CXCL-10-/- mice
at Day 4 post-infection compared with WT. This sug-
gests an elevated systemic expression of Foxp3 mRNA
and protein in CXCL-10-/- than in WT mice during the
infection. This observation is in line with recent human
studies conducted in The Gambia in West Africa where
individuals living in areas with high malaria transmission
had higher levels of regulatory T-cells compared with
those living in areas where malaria is rare [25]. However
this contrasts with other studies, which reported a
minor increase in Foxp3 expression during P. berghei
infection at Day 7 post-infection [26] (early expression
of Foxp3 was not reported in this article).
Regulatory T cells are key cerebroprotective immuno-
modulators during acute strokes in murine model.
Absence of CD4+CD25+Foxp3+ enhanced activation of
resident and invading inflammatory cells (microglia and
T-cells) to produce higher levels of TNF and IFN-g,
which are deleterious to the brain [27]. In this study, it
was determined that early up-regulation of Foxp3
(mRNA and protein) in the brain and PBMCs correlated
positively with CM protection in CXCL-10-/- mice than
in WT. Regulatory T-cells induced CD4+ T-cell apopto-
sis during the early stage of P. yoelii 17XL infection and
this in effect regulates pro-inflammatory responses [28].
Therefore, up-regulation of Foxp3 in the brain may
Figure 2 qRT-PCR and Western Blot analyses of Foxp3 in CXCL-10-/- and WT mouse brain. CXCL-10-/- and wild type C57BL/6 (n = 5-10)
were infected with P. berghei ANKA parasitized blood intra-peritoneally. Control mice were injected with uninfected blood. Infected and
uninfected mice were sacrificed at day 2, 4 & 8. Messenger RNA and protein were isolated from brain tissue samples, and qRT-PCR and Western
blot were performed using the MyiQ real-time PCR detection system (Bio-Rad, CA USA) with primers for Foxp3 and -actin as internal control and
SDS-PAGE Western blot and Foxp3, and a-tubulin antibodies respectively. P. berghei ANKA induced Foxp3 mRNA and protein expressions at day
4 in CXCL-10-/- brain were higher and statistically significant compared with the expression in WT. At day 8 p.i however, P. berghei ANKA
induced Foxp3 mRNA and protein were higher in WT brain than in CXCL-10-/. P. berghei ANKA induced early expression of Foxp3 mRNA and
protein in CXCL-10-/- than in WT.
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Figure 3 (A-C): qRT-PCR analysis of Foxp3 in CXCL-10-/- and WT mouse peripheral blood mononuclear cells (PBMC). CXCL-10-/- and
wild type C57BL/6 (n = 10) were infected with P. berghei ANKA parasitized blood intra-peritoneally. Control mice were injected with uninfected
blood. Mice were sacrificed at day 2, 4 & 8. Messenger RNA was isolated from brain tissue samples, DNase treated and quantified. One
microgram (1 μg) of DNase treated RNA was converted to cDNA and qRT-PCR was performed using the MyiQ real-time PCR detection system
(Bio-Rad, CA USA) using primers for FOXP3 and -actin as internal control. P. berghei ANKA induced Foxp3 mRNA expression at day 4 in CXCL-
10-/- PBMC was higher and statistically significant compared with WT (Figure 3C).
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could prevent parasite associated complications in the
brain. CXCL-10 itself has been associated with fatal CM
and it absence has been linked to enhanced CD4+CD25
+Foxp3+ expression and activation leading to its ability
to dampen over activation and production of pathogenic
inflammatory factors which cause CM. These taken
together could be responsible for the inhibition of CM
outcome in the CXCL-10-/- compared with the WT in
our study, compared with the study in reference 29.
Some reports indicate that expansion of CD4+CD25
+Foxp3+ during murine malaria did not prevent murine

Figure 4 (A-C): Plasma levels of IL-10 in P. berghei ANKA infected and control CXCL-10-/- and wild type C57BL/6 mice. CXCL-10-/- and
wild type C57BL/6 (n = 10) were infected with P. berghei ANKA parasitized blood intra-peritoneally. Control mice were injected with uninfected
blood. Infected and uninfected mice were sacrificed at day 2, 4 & 8. Plasma was collected and ELISA was performed to determine IL-10 levels
using the R&D systems (MN USA). IL-10 in plasma of infected mice was higher than in uninfected mice except on day 2 in infected WT (Figures
4A & 4B). Plasma level of IL-10 in infected CXCL-10-/- is significantly up-regulated compared with infected WT at day 2 and 4 post-infection
(Figure 4C). Interestingly, IL-10 at day 8 pi in WT plasma was significantly higher in WT than in CXCL-10-/-.
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Figure 5 (A-C): Plasma levels of IL-2 in P. berghei ANKA infected and control CXCL-10-/- and wild type C57BL/6 mice. CXCL-10-/- and
wild type C57BL/6 (n = 10) were infected with P. berghei ANKA parasitized blood intra-peritoneally. Control mice were injected with uninfected
blood. Mice were sacrificed at day 2, 4 & 8. Plasma was collected from infected and uninfected mice and ELISA was performed to determine IL-2
levels using the R&D systems (MN USA). There was significant induction of IL-2 in CXCL-10-/- than in WT at day 2 (statistically significant, p <
0.05) and 4 post-infection. Differences between IL-2 levels in CXCL-10-/- and WT at day 8 were not significant (error bar on plot for day 8 CXCL-
10-/- (KO) could be a potential outlier. It presence or removal did not affect the difference between the two group of mice during the analysis).
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Figure 6 (A-C): IL-10 production in P. berghei antigen re-stimulation of CD4+CD25+ and CD4+CD25- T cells from CXCL-10-/- and wild
type C57BL/6 mice. Day 4 infected mice (n = 6) spleens were harvested and peripheral blood mononuclear cells were isolated. Regulatory T
cells (CD4+CD25+) and regulatory T cells-depleted T cells (CD4+CD25-) were isolated using the Miltenyi Biotec Inc (CA, USA) isolation kit. Cells (5
×1 0
5cells/well) were re-stimulated with P. berghei antigens (Ag) (50 μg/ml) plus PMA and ionomycin. Controls consisted of cells re-stimulated
with supernatant from uninfected red blood cells (Uninf.). Cells were cultured for 5 days and IL-10 in harvested supernatants was determined by
ELISA. There was significant difference in IL-10 production between antigen (Ag) restimulated cells than in controls (Uninf) (Figures 6A and 6B).
Interestingly there was no significant difference in IL-10 levels between antigen (Ag) restimulated cells from CXCL-10-/- and WT (Figure 6C).
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+CD25+Foxp3+ suppressed CD4+ T-cell function and
inhibited the development of murine CM in Plasmo-
dium berghei-specific Th1 response [30, 31]. Increase in
numbers and activation of CD4+CD25+Foxp3+ control
the production of pro-inflammatory cytokines and med-
iate a counter-regulatory response to overwhelming
inflammation during lethal Plasmodium chabaudi
adami infection and did not contribute to parasite
immune evasion [32]. Significant up-regulation of Foxp3
mRNA and protein during P. berghei infection in
CXCL-10-/- in this study is associated with protection
a g a i n s tm u r i n eC M ;af i r s tr e p o r to ft h er o l eo fF o x p 3
gene and protein expression in severity of CM in
CXCL-10-/- mice.
It was observed in this study that IL-10 levels
increased in plasma during P. berghei infection in
CXCL-10-/- than in wild type mice. Interleukin-10 (IL-
10) is an anti-inflammatory cytokine and thus increased
production during parasite infection was necessary to
ameliorate the disease outcome. Interleukin-10 (IL-10)
levels in infected CXCL-10-/- at Days 2 and 4 were
higher than in infected WT mice. Possibly, early induc-
tion of IL-10 and Foxp3 combined to provide anti-
inflammatory responses to mediate the cerebroprotec-
tive effects against CM in CXCL-10-/- mice as evi-
denced in the absence of CM symptoms in those mice.
Regulation of proinflammatory response during murine
malaria infection is mediated by regulatory T- cells in
an IL-10 dependent manner [28]. Additionally, CD4
+CD25+Foxp3+ have recently been reported as major
cerebroprotective modulators of post-ischemic inflam-
matory brain damage with IL-10 as the predominant
associated anti-inflammatory cytokine modulating this
effect [27]. Therefore, IL-10 producing CD4+CD25
+Foxp3+ activated early in a robust inflammatory setting
through a feedback mechanism would consequently
reduce severity of CM.
In this study interleukin-2 cytokine was up-regulated in
CXCL-10-/- mice than WT. Interleukin-2 (IL-2) is a Th1
cytokine produced by activated T lymphocytes and plays
a key role in promoting the expansion of antigen-specific
T cells and also mediates multiple immune responses on
a variety of cell types including thymocytes, activated B
cells, monocytes, natural killer cells and oligodendro-
cytes. IL-2 mediates signaling through IL-2Ra, and regu-
lates Foxp3 expression in CD4+CD25+Foxp3+ [33,34].
Induction of Foxp3 during Plasmodium falciparum infec-
tion is driven by IL-2 [34]. The results showed that at
days 2 and 4, IL-2 was significantly up-regulated in
plasma of CXCL-10-/- than in WT, indicating that the
absence of CXCL-10 promotes IL-2 expression during
murine malaria and that it could play an important role
in the pathogenesis of severe malaria.
Thymus (CD4+, and CD25+ T cells) were the major
cellular source of IL-10 and TGF-b1 cytokines in
malaria infected red blood cells (iRBC) when co-cul-
tured with PBMCs [34]. CD4+CD25+ and CD4+CD25-
T-cells cultured with P. berghei antigens secreted more
of IL-10 than cells cultured with non- P. berghei super-
natant and RPMI 1640 medium alone confirming that P.
berghei parasite antigens were inducing IL-10 produc-
tion. It was observed that IL-10 production by CD4
+CD25+ T-cells from CXCL-10-/- was significantly
higher than wild type mice in vitro (Figures 6A, 6B and
6C), implying that CD4+CD25+ T-cells is a potential
source of IL-10 during malaria infection.
Taking all of the above observation together, it could
be concluded that, high levels of IL-2 in CXCL-10-/-
mice during P. berghei ANKA infection induce CD4
+CD25+Foxp3+ measured by levels of Foxp3 transcrip-
tion and translation. Subsequently it seems that activated
CD4+CD25+Foxp3+ produce high levels of IL-10, and
are able to mount a robust anti-inflammatory response,
which counter the inflammatory effects of P. berghei
parasite thus preventing fatal CM in CXCL-10-/-.
Conclusion
Plasmodium berghei ANKA infection in CXCL-10-/- mice
induces early production of T-regs expressing Foxp3 in
brain and PBMC, and IL-10 and IL-2 than in WT. Also,
CD4+CD25+ T cells from CXCL-10-/- mice produce high
levels of IL-10 than WT. CXCL-10 involvement in the
pro-inflammatory networks coupled with early activation
of Foxp3 (CD4+CD25+Foxp3+) in conjunction with IL-10
and IL-2 are important mediators of fatal murine CM,
and, therefore, strategies to regulate their expression will
have the potential to prevent fatal CM.
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